Literature DB >> 22752886

Mortality in Barrett's esophagus: three decades of experience at a single center.

C P J Caygill1, C Royston, A Charlett, C M Wall, P A C Gatenby, J R Ramus, A Watson, M Winslet, K D Bardhan.   

Abstract

BACKGROUND AND STUDY AIMS: There is a view that the majority of deaths in patients with Barrett's esophagus are from causes other than esophageal adenocarcinoma (EAC). The aim of this analysis was to establish the pattern of mortality for a number of causes in patients with Barrett's esophagus. PATIENTS AND METHODS: This was a single-center prospective cohort study of patients from Rotherham District General Hospital, which is a secondary referral center. The cohort consisted of 1239 patients who were diagnosed with Barrett's esophagus between April 1978 and March 2009.  Follow-up for mortality was undertaken by "flagging" the patients with the NHS Information Center. Causes of death were compared with UK Office of National Statistics age- and sex-specific mortality data for 1999, the median year of diagnosis. Analysis was by a "person - years at risk" calculation from date of diagnosis.
RESULTS: The ratio of observed deaths from EAC compared with those expected in this cohort was 25.02 - a very large excess. There was no difference in mortality from colorectal cancer or circulatory disease and there were fewer deaths from cancers other than esophageal adenocarcinoma and colon cancer compared with national statistics. There was a small statistically significant difference in mortality from all causes but this disappeared completely when deaths from esophageal adenocarcinoma were excluded.
CONCLUSIONS: Overall, mortality in Barrett's esophagus is increased significantly but only as a result of the large excess of deaths from EAC. This strengthens the case for endoscopic surveillance if successful interventions can be undertaken in patients with Barrett's esophagus to prevent development of esophageal adenocarcinoma. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22752886     DOI: 10.1055/s-0032-1309842

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  9 in total

1.  Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence.

Authors:  António Dias Pereira; Paula Chaves
Journal:  United European Gastroenterol J       Date:  2015-10-30       Impact factor: 4.623

2.  Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.

Authors:  Michael B Cook; Sally B Coburn; Jameson R Lam; Philip R Taylor; Jennifer L Schneider; Douglas A Corley
Journal:  Gut       Date:  2017-01-04       Impact factor: 23.059

3.  Relationship between Barrett's esophagus and colonic diseases: a role for colonoscopy in Barrett's surveillance.

Authors:  Yuji Amano; Ryotaro Nakahara; Takafumi Yuki; Daisuke Murakami; Tetsuro Ujihara; Iwaki Tomoyuki; Ryota Sagami; Satoshi Suehiro; Yasushi Katsuyama; Kenji Hayasaka; Hideaki Harada; Yasumasa Tada; Youichi Miyaoka; Hirofumi Fujishiro
Journal:  J Gastroenterol       Date:  2019-06-25       Impact factor: 7.527

Review 4.  Management controversies in Barrett's oesophagus.

Authors:  L Max Almond; Hugh Barr
Journal:  J Gastroenterol       Date:  2013-06-05       Impact factor: 7.527

5.  Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.

Authors:  Piers Gatenby; Christine Caygill; Christine Wall; Santanu Bhatacharjee; James Ramus; Anthony Watson; Marc Winslet
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

Review 6.  BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.

Authors:  Cathy Bennett; Paul Moayyedi; Douglas A Corley; John DeCaestecker; Yngve Falck-Ytter; Gary Falk; Nimish Vakil; Scott Sanders; Michael Vieth; John Inadomi; David Aldulaimi; Khek-Yu Ho; Robert Odze; Stephen J Meltzer; Eamonn Quigley; Stuart Gittens; Peter Watson; Giovanni Zaninotto; Prasad G Iyer; Leo Alexandre; Yeng Ang; James Callaghan; Rebecca Harrison; Rajvinder Singh; Pradeep Bhandari; Raf Bisschops; Bita Geramizadeh; Philip Kaye; Sheila Krishnadath; M Brian Fennerty; Hendrik Manner; Katie S Nason; Oliver Pech; Vani Konda; Krish Ragunath; Imdadur Rahman; Yvonne Romero; Richard Sampliner; Peter D Siersema; Jan Tack; Tony C K Tham; Nigel Trudgill; David S Weinberg; Jean Wang; Kenneth Wang; Jennie Y Y Wong; Stephen Attwood; Peter Malfertheiner; David MacDonald; Hugh Barr; Mark K Ferguson; Janusz Jankowski
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

7.  Simplified classification of capillary pattern in Barrett esophagus using magnifying endoscopy with narrow band imaging: implications for malignant potential and interobserver agreement.

Authors:  Goichi Uno; Norihisa Ishimura; Yasumasa Tada; Yuji Tamagawa; Takafumi Yuki; Takashi Matsushita; Shunji Ishihara; Yuji Amano; Riruke Maruyama; Yoshikazu Kinoshita
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

8.  Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus.

Authors:  Akira Yamasaki; Tomoki Shimizu; Hiroshi Kawachi; Noriko Yamamoto; Shoichi Yoshimizu; Yusuke Horiuchi; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Tomohiro Tsuchida; Yutaka Sasaki; Junko Fujisaki
Journal:  J Gastroenterol Hepatol       Date:  2019-09-01       Impact factor: 4.029

Review 9.  How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurements.

Authors:  Mirjam C M van der Ende-van Loon; A Stoker; P T Nieuwkerk; W L Curvers; E J Schoon
Journal:  Qual Life Res       Date:  2021-11-08       Impact factor: 3.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.